SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Back to LSTA Full portfolio

Position in LSTA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$58,136

+$25,079 QoQ

Shares Held

11,604

+5.3% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Derivatives in LSTA

reported options exposure · as of Sep 30, 2022

CallValue

$90,748

CallShares

19,600

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. LSTA ranks #329 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	898,951	$59,249,860
2	ALNY	Alnylam Pharmaceuticals, Inc.	174,268	$57,660,053
3	AGIO	Agios Pharmaceuticals, Inc.	1,344,953	$45,499,759
4	ABVX	Abivax S.A.	381,282	$42,455,750
5	BBIO	BridgeBio Pharma, Inc.	398,943	$29,625,507
6	INSM	INSMED Inc	173,630	$28,391,977
7	CRSP	CRISPR Therapeutics AG	593,406	$28,228,323
8	TERN	Terns Pharmaceuticals, Inc.	521,571	$27,497,223

All Filings in LSTA

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$58,136	11,604	+5.3%	Shares	Other	2026-05-15
2024-09-30	$33,057	11,019	+2.8%	Shares	Defined	2024-11-14
2024-03-31	$33,443	10,719	-68.2%	Shares	Defined	2024-05-07
2023-12-31	$92,134	33,749	+72.2%	Shares	Defined	2024-02-14
2022-09-30	$90,748	19,600	—	Call	Defined	2022-11-14
No filing history on record for this holder in this stock.